Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Osteoporosis

  Free Subscription


28.10.2019

3 J Clin Endocrinol Metab
2 J Rheumatol
5 Osteoporos Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Clin Endocrinol Metab

  1. SUGIYAMA T
    Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602688. doi: 10.1210.
    PubMed     Text format    

  2. MURAI IH, Roschel H, Gualano B
    Response to Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602687. doi: 10.1210.
    PubMed     Text format    

  3. MERLOTTI D, Rendina D, Muscariello R, Picchioni T, et al
    PREVENTIVE ROLE OF VITAMIN D SUPPLEMENTATION FOR ACUTE PHASE REACTION AFTER BISPHOSPHONATE INFUSION IN PAGET'S DISEASE.
    J Clin Endocrinol Metab. 2019 Oct 22. pii: 5601913. doi: 10.1210.
    PubMed     Text format     Abstract available


    J Rheumatol

  4. BEST JH, Kong AM, Lenhart GM, Sarsour K, et al
    Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2018 Jan 15. pii: jrheum.170418. doi: 10.3899/jrheum.170418.
    PubMed     Text format     Abstract available

  5. LAU AN, Wong-Pack M, Rodjanapiches R, Ioannidis G, et al
    Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting.
    J Rheumatol. 2017 Nov 15. pii: jrheum.161270. doi: 10.3899/jrheum.161270.
    PubMed     Text format     Abstract available


    Osteoporos Int

  6. LESLIE WD
    Bisphosphonates and lower mortality risk: when it sounds to be good to be true ....
    Osteoporos Int. 2019 Oct 19. pii: 10.1007/s00198-019-05157.
    PubMed     Text format    

  7. WU CH, Kao IJ, Hung WC, Lin SC, et al
    Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4411.
    PubMed     Text format     Abstract available

  8. DELL R, Greene D
    A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Osteoporos Int. 2018 Apr 19. pii: 10.1007/s00198-018-4506.
    PubMed     Text format     Abstract available

  9. GEUSENS P, van den Bergh J
    Comments on Kanis et al.: Characteristics of recurrent fractures.
    Osteoporos Int. 2018 Dec 18. pii: 10.1007/s00198-018-4735.
    PubMed     Text format    

  10. KENDLER DL, Bone HG, Massari F, Gielen E, et al
    Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
    Osteoporos Int. 2019 Oct 18. pii: 10.1007/s00198-019-05146.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: